Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Collaboration provides healthcare commercialization programmes

Quintiles : 08 January, 2014  (Company News)
Quintiles has joined the Medical Affairs Company in a collaboration for extended medical science liaison capabilities
Collaboration provides healthcare commercialization programmes


Quintiles and The Medical Affairs Company (TMAC) have announced a new collaboration that will extend and enhance each company’s existing medical affairs-related offerings for customers in the United States.



Under the agreement, Quintiles will add TMAC’s industry-leading medical science liaison (MSL) capabilities to its existing field-based medical solutions, providing customers with additional expertise to engage opinion leaders and encourage a heightened knowledge of research, products and devices. The collaboration will also allow TMAC to make use of Quintiles’ clinical educators with its clients to facilitate ongoing education of healthcare professionals, patients and caregivers throughout the USA.



“Today, more than ever before, biopharmaceutical companies looking to commercialize products in the USA are focused on demonstrating the value and benefits of their products to an increasingly diverse range of stakeholders,” said Daryl Gaugler, senior vice president, Commercial Solutions at Quintiles. “As this stakeholder landscape and its requirements continue to evolve, we are delighted to be working alongside a company like TMAC to offer the full spectrum of commercialization services, with an integrated approach to sales, medical science liaison, clinical education and market entry.



“This collaboration will extend and enhance our ability to deliver integrated commercialization programs for our customers, including for small to medium sized companies, as they consider their options for developing capabilities in the US market.”



Working together, Quintiles and TMAC will continue to provide customers with the integrated, multi-disciplinary teams they have come to expect from both companies, but now with an added breadth of expertise. Both companies will utilize the services of the other to bolster existing capabilities and provide comprehensive solutions to their customers in the USA.



“Requirements for medical affairs activities are expanding across the product life cycle,” said Evan Demestihas, MD, chief executive officer, TMAC. “Working with companies like TMAC and Quintiles provides customers with benefits in terms of strategic oversight, speedy deployment and operational flexibility, while maintaining the discipline-specific and therapy area expertise that are essential to medical affairs teams. Through this collaboration, we believe Quintiles and TMAC will offer customers turn-key field commercialization capabilities that are unmatched in our industry.”


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo